These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 32417271)

  • 1. Modeling epileptic spasms during infancy: Are we heading for the treatment yet?
    Velíšek L; Velíšková J
    Pharmacol Ther; 2020 Aug; 212():107578. PubMed ID: 32417271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocorticotropic hormone for the treatment of West Syndrome in children.
    Shumiloff NA; Lam WM; Manasco KB
    Ann Pharmacother; 2013 May; 47(5):744-54. PubMed ID: 23606552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Outcomes in Infantile Spasms: Role of Pharmacotherapy.
    Iyer A; Appleton R
    Paediatr Drugs; 2016 Oct; 18(5):357-66. PubMed ID: 27541933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk-benefit assessment of treatments for infantile spasms.
    Nabbout R
    Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment modalities for infantile spasms: current considerations and evolving strategies in clinical practice.
    Hollenshead PP; Jackson CN; Cross JV; Witten TE; Anwar AI; Ahmadzadeh S; Shekoohi S; Kaye AD
    Neurol Sci; 2024 Feb; 45(2):507-514. PubMed ID: 37736852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AQB-565 shows promise in preclinical testing in the model of epileptic spasms during infancy: Head-to-head comparison with ACTH.
    Chern CR; Chern CJ; Velíšková J; Velíšek L
    Epilepsy Res; 2019 May; 152():31-34. PubMed ID: 30875634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of infantile spasms.
    Haines ST; Casto DT
    Ann Pharmacother; 1994 Jun; 28(6):779-91. PubMed ID: 7919570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epileptic spasms in CDKL5 deficiency disorder: Delayed treatment and poor response to first-line therapies.
    Olson HE; Demarest S; Pestana-Knight E; Moosa AN; Zhang X; Pérez-Pérez JR; Weisenberg J; O'Connor Prange E; Marsh ED; Rajaraman RR; Suter B; Katyayan A; Haviland I; Daniels C; Zhang B; Greene C; DeLeo M; Swanson L; Love-Nichols J; Benke T; Harini C; Poduri A
    Epilepsia; 2023 Jul; 64(7):1821-1832. PubMed ID: 37114835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACTON PROLONGATUM® suppresses spasms head to head with Acthar® Gel in the model of infantile spasms.
    Chern CR; Chern CJ; Velíšková J; Velíšek L
    Epilepsy Behav; 2020 Apr; 105():106950. PubMed ID: 32092460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Treatments for Infantile Spasms: A Systematic Review.
    Song JM; Hahn J; Kim SH; Chang MJ
    Clin Neuropharmacol; 2017; 40(2):63-84. PubMed ID: 28288483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatment of patients with infantile spasms.
    Mikati MA; Lepejian GA; Holmes GL
    Clin Neuropharmacol; 2002; 25(2):61-70. PubMed ID: 11981230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update of the medical treatment of West syndrome.
    Verrotti A; Manco R; Coppola GG; Mingione S; Chiarelli F; Iannetti P
    Minerva Pediatr; 2007 Jun; 59(3):249-53. PubMed ID: 17519870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A plausible explanation for superiority of adreno-cortico-trophic hormone (ACTH) over oral corticosteroids in management of infantile spasms (West syndrome).
    Jaseja H
    Med Hypotheses; 2006; 67(4):721-4. PubMed ID: 16781824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.
    Ibrahim S; Gulab S; Ishaque S; Saleem T
    BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infantile spasms and West syndrome].
    Diaconu G; Grigore I
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):40-5. PubMed ID: 15688754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
    O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infantile Spasms: Outcome in Clinical Studies.
    Riikonen R
    Pediatr Neurol; 2020 Jul; 108():54-64. PubMed ID: 32305143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the pharmacotherapy of infantile spasms.
    Riikonen R
    CNS Drugs; 2014 Apr; 28(4):279-90. PubMed ID: 24504827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocorticotropic hormone versus prednisolone in the treatment of infantile spasms post vigabatrin failure.
    Jones K; Snead OC; Boyd J; Go C
    J Child Neurol; 2015 Apr; 30(5):595-600. PubMed ID: 24965788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol.
    Eliyan Y; Heesch J; Alayari A; Rajaraman RR; Sankar R; Hussain SA
    Pediatr Neurol; 2019 Oct; 99():16-22. PubMed ID: 31331669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.